ClinConnect ClinConnect Logo
Search / Trial NCT05542914

Electronic SBI(RT) for MSM in Argentina

Launched by FLORIDA STATE UNIVERSITY · Sep 13, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Sbirt Hiv Prevention Msm

ClinConnect Summary

This clinical trial is looking at a new program designed to help men who have sex with men (MSM) in Argentina who may be struggling with substance use and are at risk for HIV. The program uses a tablet-based tool to ask questions about drug and alcohol use, as well as sexual behaviors, while these men are waiting for their HIV test results. The goal is to identify those who may need support and provide them with a brief counseling session and referrals to treatment if necessary. The researchers want to see if this program is easy to use and if it helps participants reduce their substance use and risky behaviors.

To participate in this study, men must be at least 18 years old, have had sex with other men in the past six months, and be seeking an HIV test at the Nexo clinic in Buenos Aires. They also need to report using drugs at least once a month or show signs of moderate alcohol use. Participants can expect to engage in a brief intervention tailored to their needs, and their feedback will help improve the program for future use. This trial is important because it aims to connect MSM with the help they need, potentially reducing both substance abuse and the risk of HIV.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • * Participants in Stage 1 Focus Groups (FGs) and in-depth interviews (IDIs):
  • 1. Man who has had sex with men in the past 6 months;
  • 2. 18 years of age or older;
  • 3. Recently sought an HIV test at Nexo;
  • 4. Reports using drugs least once per month in the past 6 months and/or score 4 or greater on the AUDIT C, suggesting moderate risk alcohol use.
  • Participants in Stage 1 e-SBI pilot and the Stage 2 RCT:
  • 1. Man who has had sex with men in the past 6 months
  • 2. 18 years of age or older;
  • 3. Currently seeking an HIV test at Nexo
  • Additional inclusion criteria for MHP entry:
  • 1. Score of moderate or high risk drug or alcohol use based on the ASSIST and AUDIT, respectively
  • Exclusion Criteria:
  • * Exclusion Criteria for MHP entry:
  • 1. be in need of acute detoxification, as demonstrated by physical withdrawal symptoms or a history of withdrawal, such as previous delirium tremens or seizures
  • 2. reported regular use of opioids
  • 3. enrolled in concurrent drug- or alcohol-related treatment.

About Florida State University

Florida State University (FSU) is a prestigious public research institution located in Tallahassee, Florida, known for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, FSU leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the medical community. The university fosters a collaborative environment that brings together multidisciplinary teams to design, implement, and analyze clinical studies, ensuring adherence to the highest ethical and scientific standards. Through its clinical trials, FSU aims to address critical health challenges and translate research findings into practical applications that benefit society.

Locations

Buenos Aires, , Argentina

Patients applied

0 patients applied

Trial Officials

Ivan C Balan

Principal Investigator

Florida State University, College of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials